Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose
incidence increases in parallel with the severity of cirrhosis. Several risk factors have been …

Description This expert review was commissioned and approved by the AGA Institute
Clinical Practice Updates Committee and the AGA Governing Board to provide timely …

Cirrhosis is an increasing cause of morbidity and mortality in more developed countries,
being the 14th most common cause of death worldwide but fourth in central Europe …

In cirrhosis, portal vein thrombosis (PVT) could be a cause or a consequence of the
progression of liver disease. We analyzed data from a prospective trial of ultrasound …

BACKGROUND & AIMS: We performed a randomized controlled trial to evaluate the safety
and efficacy of enoxaparin, a low-molecular-weight heparin, in preventing portal vein …

Patients with liver disease frequently acquire a complex disorder of hemostasis secondary to
their disease. Routine laboratory tests such as the prothrombin time and the platelet count …

Patients with chronic or acute liver failure frequently show profound abnormalities in their
hemostatic system. Whereas routine laboratory tests of hemostasis suggest these …

Portal vein thrombosis is not uncommon in candidates for transplantation. Partial thrombosis
is more common than complete thrombosis. Despite careful screening at evaluation, a …

Background There is no established management algorithm for portal vein thrombosis (PVT)
in cirrhotic patients. The aim of our study was to prospectively evaluate anticoagulation and …

The modality and context of assessment of PVT may influence the prevalence rate of PVT in
patients with cirrhosis, being 0.6% when evaluated by percutaneous angiographic studies …